Your browser doesn't support javascript.
loading
The KAG motif of HLA-DRB1 (ß71, ß74, ß86) predicts seroconversion and development of type 1 diabetes.
Zhao, Lue Ping; Papadopoulos, George K; Lybrand, Terry P; Moustakas, Antonis K; Bondinas, George P; Carlsson, Annelie; Larsson, Helena Elding; Ludvigsson, Johnny; Marcus, Claude; Persson, Martina; Samuelsson, Ulf; Wang, Ruihan; Pyo, Chul-Woo; Nelson, Wyatt C; Geraghty, Daniel E; Rich, Stephen S; Lernmark, Åke.
Afiliación
  • Zhao LP; Public Health Sciences Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave NE, Seattle, WA 98109, USA. Electronic address: lzhao@fredhutch.org.
  • Papadopoulos GK; Laboratory of Biophysics, Biochemistry, Biomaterials and Bioprocessing, Faculty of Agricultural Technology, Technological Educational Institute of Epirus, Arta GR47100, Greece. Electronic address: papadopg@gmail.com.
  • Lybrand TP; Department of Chemistry, Department of Pharmacology and Center for Structural Biology, Vanderbilt University, Nashville, TN, United States.
  • Moustakas AK; Department of Food Science and Technology, Faculty of Environmental Sciences, Ionian University, Argostoli GR26100, Cephalonia, Greece.
  • Bondinas GP; Laboratory of Biophysics, Biochemistry, Biomaterials and Bioprocessing, Faculty of Agricultural Technology, Technological Educational Institute of Epirus, Arta GR47100, Greece.
  • Carlsson A; Department of Clinical Sciences, Lund University, Skåne University Hospital, Lund, Sweden.
  • Larsson HE; Department of Clinical Sciences, Lund University CRC, Skåne University Hospital, Jan Waldenströms gata 35, Skåne University Hospital SUS, Malmö SE-205 02, Sweden.
  • Ludvigsson J; Crown Princess Victoria Children´s Hospital and Div of Pediatrics, Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.
  • Marcus C; Department of Clinical Science and Education Karolinska Institutet and Institution of Medicine, Clinical Epidemiology, Karolinska Institutet, Stockholm, Sweden.
  • Persson M; Department of Medicine, Clinical Epidemiological Unit, Karolinska Institutet, Stockholm, Sweden.
  • Samuelsson U; Crown Princess Victoria Children´s Hospital and Div of Pediatrics, Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.
  • Wang R; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States.
  • Pyo CW; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States.
  • Nelson WC; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States.
  • Geraghty DE; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States.
  • Rich SS; Center for Public Health Genomics, University of Virginia, PO Box 800717, MSB Room 3232, 1300 Jefferson Park Ave, Charlottesville, VA 22908, United States. Electronic address: ssr4n@virginia.edu.
  • Lernmark Å; Department of Clinical Sciences, Lund University CRC, Skåne University Hospital, Jan Waldenströms gata 35, Skåne University Hospital SUS, Malmö SE-205 02, Sweden. Electronic address: ake.lernmark@med.lu.se.
EBioMedicine ; 69: 103431, 2021 Jul.
Article en En | MEDLINE | ID: mdl-34153873
BACKGROUND: HLA-DR4, a common antigen of HLA-DRB1, has multiple subtypes that are strongly associated with risk of type 1 diabetes (T1D); however, some are risk neutral or resistant. The pathobiological mechanism of HLA-DR4 subtypes remains to be elucidated. METHODS: We used a population-based case-control study of T1D (962 patients and 636 controls) to decipher genetic associations of HLA-DR4 subtypes and specific residues with susceptibility to T1D. Using a birth cohort of 7865 children with periodically measured islet autoantibodies (GADA, IAA or IA-2A), we proposed to validate discovered genetic associations with a totally different study design and time-to-seroconversions prior to clinical onset of T1D. A novel analytic strategy hierarchically organized the HLA-DRB1 alleles by sequence similarity and identified critical amino acid residues by minimizing local genomic architecture and higher-order interactions. FINDINGS: Three amino acid residues of HLA-DRB1 (ß71, ß74, ß86) were found to be predictive of T1D risk in the population-based study. The "KAG" motif, corresponding to HLA-DRB1×04:01, was most strongly associated with T1D risk ([O]dds [R]atio=3.64, p = 3.19 × 10-64). Three less frequent motifs ("EAV", OR = 2.55, p = 0.025; "RAG", OR = 1.93, p = 0.043; and "RAV", OR = 1.56, p = 0.003) were associated with T1D risk, while two motifs ("REG" and "REV") were equally protective (OR = 0.11, p = 4.23 × 10-4). In an independent birth cohort of HLA-DR3 and HLA-DR4 subjects, those having the "KAG" motif had increased risk for time-to-seroconversion (Hazard Ratio = 1.74, p = 6.51 × 10-14) after adjusting potential confounders. INTERPRETATIONS: DNA sequence variation in HLA-DRB1 at positions ß71, ß74, and ß86 are non-conservative (ß74 A→E, ß71 E vs K vs R and ß86 G vs V). They result in substantial differences in peptide antigen anchor pocket preferences at p1, p4 and potentially neighboring regions such as pocket p7. Differential peptide antigen binding is likely to be affected. These sequence substitutions may account for most of the HLA-DR4 contribution to T1D risk as illustrated in two HLA-peptide model complexes of the T1D autoantigens preproinsulin and GAD65. FUNDING: National Institute of Diabetes and Digestive and Kidney Diseases and the Swedish Child Diabetes Foundation and the Swedish Research Council.
Asunto(s)
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 1 / Cadenas HLA-DRB1 / Seroconversión Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Child / Child, preschool / Female / Humans / Infant / Male Idioma: En Revista: EBioMedicine Año: 2021 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 1 / Cadenas HLA-DRB1 / Seroconversión Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Child / Child, preschool / Female / Humans / Infant / Male Idioma: En Revista: EBioMedicine Año: 2021 Tipo del documento: Article